Detection of malignant effusions: Comparison of a telomerase assay and cytologic examination
Corresponding Author
Richard Braunschweig M.D.
Institut de Pathologie, Centre Hospitalier Universitaire Vaudois, Lausanne
Institut de Pathologie, Centre Hospitalier Universitaire Vaudois, Bugnon 25, CH-1011 Lausanne, SwitzerlandSearch for more papers by this authorPu Yan M.D.
Institut de Pathologie, Centre Hospitalier Universitaire Vaudois, Lausanne
Search for more papers by this authorIsabelle Guilleret M.Sc.
Institut de Pathologie, Centre Hospitalier Universitaire Vaudois, Lausanne
Search for more papers by this authorFrançoise Delacretaz M.D.
Institut de Pathologie, Centre Hospitalier Universitaire Vaudois, Lausanne
Search for more papers by this authorFred T. Bosman M.D., Ph.D.
Institut de Pathologie, Centre Hospitalier Universitaire Vaudois, Lausanne
Search for more papers by this authorAnca Mihaescu M.D.
Institut de Pathologie, Centre Hospitalier Universitaire Vaudois, Lausanne
Search for more papers by this authorJean Benhattar Ph.D.
Institut de Pathologie, Centre Hospitalier Universitaire Vaudois, Lausanne
Search for more papers by this authorCorresponding Author
Richard Braunschweig M.D.
Institut de Pathologie, Centre Hospitalier Universitaire Vaudois, Lausanne
Institut de Pathologie, Centre Hospitalier Universitaire Vaudois, Bugnon 25, CH-1011 Lausanne, SwitzerlandSearch for more papers by this authorPu Yan M.D.
Institut de Pathologie, Centre Hospitalier Universitaire Vaudois, Lausanne
Search for more papers by this authorIsabelle Guilleret M.Sc.
Institut de Pathologie, Centre Hospitalier Universitaire Vaudois, Lausanne
Search for more papers by this authorFrançoise Delacretaz M.D.
Institut de Pathologie, Centre Hospitalier Universitaire Vaudois, Lausanne
Search for more papers by this authorFred T. Bosman M.D., Ph.D.
Institut de Pathologie, Centre Hospitalier Universitaire Vaudois, Lausanne
Search for more papers by this authorAnca Mihaescu M.D.
Institut de Pathologie, Centre Hospitalier Universitaire Vaudois, Lausanne
Search for more papers by this authorJean Benhattar Ph.D.
Institut de Pathologie, Centre Hospitalier Universitaire Vaudois, Lausanne
Search for more papers by this authorAbstract
Telomerase is inactive in most somatic cells, but has been found to be reactivated in a majority of cancers. Our principal goal was to test whether the presence of telomerase activity concurred with positive cytology, and was thus of potential use in detecting cancer cells in effusions. The telomeric repeat amplification protocol (TRAP) assay and cytological examination were performed in a blinded fashion on 91 unselected effusions, for which laboratory processing was done according to standard procedures. In our series, 30% (27/91) of samples were found to be malignant by cytology. Of these, 19 (70%) were also positive in the TRAP assay. Of the 8 telomerase-negative cytology-positive samples, RNA integrity was generally poor, indicating suboptimal sample conservation for molecular analysis. Negative cytology in the presence of telomerase activity was observed in 17 effusions. Of these, 11 were from patients with advanced cancer, and thus a diagnosis of malignant effusion should be suspected. The TRAP assay for telomerase activity holds promise in the analysis of effusions, but its routine use as an adjunct to cytology awaits further confirmation of its positive predictive value. Diagn. Cytopathol. 2001;24:174–180. © 2001 Wiley-Liss, Inc.
REFERENCES
- 1 Ehya H. Effusion cytology. Clin Lab Med 1991; 11: 443–467.
- 2
Johnston WW.
The malignant pleural effusion. A review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients.
Cancer
1985;
56:
905–909.
10.1002/1097-0142(19850815)56:4<905::AID-CNCR2820560435>3.0.CO;2-U CAS PubMed Web of Science® Google Scholar
- 3 Sahn SA. Malignancy metastatic to the pleura. Clin Chest Med 1998; 19: 351–361.
- 4
Lai CR,
Pan CC,
Tsay SH.
Contribution of immunocytochemistry in routine diagnostic cytology.
Diagn Cytopathol
1996;
14:
221–225.
10.1002/(SICI)1097-0339(199604)14:3<221::AID-DC5>3.0.CO;2-K CAS PubMed Web of Science® Google Scholar
- 5
Delahaye M,
van der Ham F,
van der Kwast TH.
Complementary value of five carcinoma markers for the diagnosis of malignant mesothelioma, adenocarcinoma metastasis, and reactive mesothelium in serous effusions.
Diagn Cytopathol
1997;
17:
115–120.
10.1002/(SICI)1097-0339(199708)17:2<115::AID-DC6>3.0.CO;2-F CAS PubMed Web of Science® Google Scholar
- 6 Dewald G, Dines DE, Weiland LH, Gordon H. Usefulness of chromosome examination in the diagnosis of malignant pleural effusions. N Engl J Med 1976; 295: 1494–1500.
- 7 Singh G, Dekker A, Ladoulis CT. Tissue culture of cells in serous effusions. Evaluation as an adjunct to cytology. Acta Cytol 1978; 22: 487–489.
- 8 Rijken A, Dekker A, Taylor S, Hoffman P, Blank M, Krause JR. Diagnostic value of DNA analysis in effusions by flow cytometry and image analysis. A prospective study on 102 patients as compared with cytologic examination. Am J Clin Pathol 1991; 95: 6–12.
- 9
O'Leary TJ.
Flow cytometry in diagnostic cytology.
Diagn Cytopathol
1998;
18:
41–46.
10.1002/(SICI)1097-0339(199801)18:1<41::AID-DC7>3.0.CO;2-X CAS PubMed Web of Science® Google Scholar
- 10 Decker D, Stratmann H, Springer W, Schwering H, Varnai N, Bollmann R. Benign and malignant cells in effusions—diagnostic value of image DNA cytometry in comparison to cytological analysis. Pathol Res Pract 1998; 194: 791–795.
- 11
Matter-Walstra KW,
Kraft R.
Atypical cells in effusions: diagnostic value of cell image analysis combined with immunocytochemistry.
Diagn Cytopathol
1996;
15:
263–269.
10.1002/(SICI)1097-0339(199611)15:4<263::AID-DC3>3.0.CO;2-F CAS PubMed Web of Science® Google Scholar
- 12 Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011–2015.
- 13
Wright WE,
Piatyszek MA,
Rainey WE,
Byrd W,
Shay JW.
Telomerase activity in human germline and embryonic tissues and cells.
Dev Genet
1996;
18:
173–179.
10.1002/(SICI)1520-6408(1996)18:2<173::AID-DVG10>3.0.CO;2-3 CAS PubMed Web of Science® Google Scholar
- 14 Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S, Greider CW. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 1996; 56: 645–650.
- 15 Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, Shay JW, Ishioka S, Yamakido M. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995; 155: 3711–3715.
- 16 Broccoli D, Young JW, de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 1995; 92: 9082–9086.
- 17 Harle-Bachor C, Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 1996; 93: 6476–6481.
- 18 Hiyama E, Hiyama K, Tatsumoto N, Shay JW, Yokoyama T. Telomerase activity in human intestine. Int J Oncol 1996; 9: 453–458.
- 19 Greider C. Mammalian telomere dynamics: healing, fragmentation shortening and stabilization. Curr Opin Genet Dev 1994; 4: 203–211.
- 20 Morin GB. The human telomerase terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989; 59: 521–529.
- 21 Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997; 277: 955–959.
- 22 Shay JW, Bacchetti SA. Survey of telomerase activity in human cancer. Eur J Cancer 1997; 33: 787–791.
- 23 Yan P, Bosman FT, Benhattar J. Tissue quality is an important determinant of telomerase activity as measured by the TRAP assay. Biotechniques 1998; 25: 660–662.
- 24 Kim NW, Wu F. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res 1997; 25: 2595–2597.
- 25 Igarashi H, Sakaguchi N. Telomerase activity is induced in human peripheral B lymphocytes by the stimulation to antigen receptor. Blood 1997; 89: 1299–1307.
- 26 Hohaus S, Voso MT, Orta-La Barbera E, Cavallo S, Bellacosa A, Rutella S, Rumi C, Genuardi M, Neri G, Leone G. Telomerase activity in human hematopoietic progenitor cells. Haematologica (Budap) 1997; 82: 262–268.
- 27 Yui J, Chiu CP, Lansdorp PM. Telomerase activity in candidate stem cells from fetal liver and adult bone marrow. Blood 1998; 91: 3255–3262.
- 28 Suehara N, Mizumoto K, Kusumoto M, Niiyama H, Ogawa T, Yamaguchi K, Yokohata K, Tanaka M. Telomerase activity detected in pancreatic juice 19 months before a tumor is detected in a patient with pancreatic cancer. Am J Gastroenterol 1998; 93: 1967–1971.
- 29 Ramsey-Goldman R, Mattai SA, Schilling E, Chiu YL, Alo CJ, Howe HL, Manzi S. Increased risk of malignancy in patients with systemic lupus erythematosus. J Invest Med 1998; 46: 217–222.
- 30 Safadi R, Berkman N, Haviv YS, Ben-Yehuda A, Amir G, Naparstek Y. Primary non-Hodgkin's lymphoma of the lung presenting as bronchiolitis obliterans organizing pneumonia. Leuk Lymphoma 1997; 28: 209–213.
- 31 Yang CT, Lee MH, Lan RS, Chen JK. Telomerase activity in pleural effusions: diagnostic significance. J Clin Oncol 1998; 16: 567–673.
- 32 Yahata N, Ohyashiki K, Ohyashiki JH, Iwama H, Hayashi S, Ando K, Hirano T, Tsuchida T, Kato H, Shay JW, Toyama K. Telomerase activity in lung cancer cells obtained from bronchial washings. J Natl Cancer Inst 1998; 90: 684–690.
- 33 Aoki K. Excess incidence of lung cancer among pulmonary tuberculosis patients. Jpn J Clin Oncol 1993; 23: 205–220.
- 34 Dacosta NA, Kinare SG. Association of lung carcinoma and tuberculosis. J Postgrad Med 1991; 37: 185–189.
- 35 Yang CT, Lin MC, Huang CC, Chen NH, Chen JK. Tuberculin purified protein derivative up-regulates the telomerase activity of peripheral blood mononuclear cells from patients with pulmonary tuberculosis. Life Sci 1999; 64: 1383–1391.
- 36 Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 1997; 3: 1271–1274.
- 37 Reddel RR, Bryan TM, Murnane JP. Immortalized cells with no detectable telomerase activity. A review. Biochemistry 1997; 62: 1254–1262.